Insider · CIK 0002081681
Rajat Mehta
Files at BIO (BIO-RAD LABORATORIES, INC.). First filing -, latest -.
In brief
Rajat Mehta files SEC Form 4 as officer at BIO (BIO-RAD LABORATORIES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Rajat Mehta has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 5, 2026 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +456 | $0.00 | $0 | 599 | 34 d ago |
| Sep 5, 2026 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -233 | $386.11 | $90k | 366 | 34 d ago |
| Sep 5, 2026 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +1,370 | $0.00 | $0 | 1,736 | 34 d ago |
| Sep 5, 2026 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -504 | $386.11 | $195k | 1,232 | 34 d ago |
| Sep 4, 2026 | BIO BIO-RAD LABORATORIES, INC. | AGrant or award Restricted Stock Unitsderivative | +4,601 | $0.00 | $0 | 4,601 | 34 d ago |
| Sep 5, 2026 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -456 | $0.00 | $0 | 1,371 | 34 d ago |
| Sep 5, 2026 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -1,370 | $0.00 | $0 | 4,110 | 34 d ago |
| Sep 5, 2025 | BIO BIO-RAD LABORATORIES, INC. | AGrant or award Restricted Stock Unitsderivative | +1,827 | $0.00 | $0 | 1,827 | Sep 9, 2025 |
| Sep 5, 2025 | BIO BIO-RAD LABORATORIES, INC. | AGrant or award Restricted Stock Unitsderivative | +5,480 | $0.00 | $0 | 5,480 | Sep 9, 2025 |
Questions about Rajat Mehta
Answered from the filings on this page, as of the latest one.
Is Rajat Mehta buying or selling?
Rajat Mehta has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Rajat Mehta's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rajat Mehta has 0.
Where does Rajat Mehta file Form 4?
Rajat Mehta has filed Form 4 at BIO (BIO-RAD LABORATORIES, INC.) as EVP, GBL Commercial Operations. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.